We’ve all experienced that moment when a hospital, ER or doctor’s office hands you an information sheet that is poorly written, technical and hard to understand. Seremedi has organized such information into a virtual care platform that helps healthcare providers to better prepare patients for procedures, provide patients faster recovery at home, and address acute and chronic care concerns as it greatly improves communication between patient and doctor.
Blog
Love of a child in need can give a person incredible focus. In 2012, Monica’s four-year-old son was the first child at Texas Children’s Genetics Clinic to be diagnosed with the gene mutation SYNGAP1. Genomic sequencing, and the rapid growth of social media, created the perfect opportunity for Monica to identify other parents seeking information about the same rare, intellectual disability.
More than 6 million Americans suffer from congestive heart failure, which leads to expensive hospital readmissions and, ultimately, a reduced quality of life. Alleviant is creating a minimally-invasive device to reduce the symptoms and functional limitations of this disease.
The U.S. is not the only biomedical super power working to make huge strides in medicine. At the BioMed X Innovation Center in Germany, big pharma uses crowd sourcing to create teams of brainpower that solve specific medical challenges under the guidance of mentors.
Our medical system is broken. It’s being run by insurance companies, which is not very rewarding for the physicians. The fact that most physicians are not very good businessmen only exacerbates the situation.
Brain injury treatment has been slow to change. In 2013, a group of medical device entrepreneurs set out to change that. Their first product is a gravity-based system that drains cerebral spinal fluid and monitors cranial pressure, a solution with an impressive list of benefits.
Two years ago Paulo Pinheiro saw a girl in a wheelchair with an unforgettable smile and decided then he had to translate that smile into commands to control her motorized wheelchair. Today, his company, HOOBOX is improving autonomy and mobility for the physically challenged through facial expressions.
Let’s face it: exits are the best part of being an entrepreneur. But most entrepreneurs have too little experience to be comfortable with the sale of their business. Basil Peters explains the importance of experience, strategy and experience in all facets of the quality sale. You need a good mentor!
Fibralign is focused on treating issues resulting from lymphedema but holds tremendous promise and farther-reaching potential. Its BioBridge product is a collagen scaffold made from a thin membrane that helps to form new blood and lymphatic vessels.
What’s hot in medical startups? Russ asks Tom Luby, head of JLABS, Texas in Houston, a medical technology incubator and a division of Johnson & Johnson Innovation. JLABS’ portfolio includes more than 40 emerging (and impressive) oncology therapeutic, pharmaceutical, medical device, consumer and digital health companies.
Angioplasty was a game-changer in the treatment of cardiovascular disease and it set a course for John Simpson’s career in cardiology. Avinger’s Pantheris line has expanded the uses of the concept and created additional medical devices to improve the way coronary artery disease is treated. Another story of entrepreneurial genius!
Telemedicine once meant speaking with the doctor over the phone. Today it means so much more! Seeing the doctor virtually for pre-op, post-op, maintenance and follow-up, insulin therapy and monitoring—and we could go on—are only the tip of the iceberg. Whittington and Hochschuler believe we have the tools to lower our costs and improve the experience for patients. Is this the future of medicine?
What started as a software company launched by four teenagers evolved into a major magnetic imaging platform for emergency rooms; in the process, they may have shifted the trajectory of “chest pain” triage testing. The geniuses of Genetesis have developed technology to rapidly rule out a heart attack as the cause of chest pain.
Successful medicine—for both patient and physician—is more than science or running a business/practice. In her new book, Fischer-Wright, author of “Back to Balance: The Art, Science and Business of Medicine,” discusses the three areas necessary to truly conduct a successful medical relationship.
Some believe that innovation in the future will occur at the molecular level through nanotechnology. Otomagnetics is developing a magnetic therapy delivery system for ear, eye and skin ailments that are difficult to treat through traditional methods. Magnets help target and “inject” nanoparticles without needles or punctures. Dr. Benjamin Shapiro explains this incredible new concept.
Three years ago, the 21 hospitals that make up the Texas Medical Center launched the TMC Innovation Institute to facilitate collaboration among the amazing innovation, research and medical progress occurring daily in the Medical Center. The program has been incredibly successful supporting and investing in these new discoveries.
Your company has a vision of what comes next, but does it have the expertise to get there? Healthcare management ecosystem Symbotix specializes in business reinvention and helps client companies reach the next level by empowering their employees to facilitate adoption and assimilation of new solutions.
Diabetes advocate and entrepreneur Mike Moradi, a biochemist, was one of the first to join AngelMD. Sensulin is developing the next-gen insulin and could be a game-changer for both Type 1 and Type 2 Diabetes patients.
Another totally disruptive genius, neurologist Geoffrey Ling sees a problem and rips right through it. As the US Army’s premier expert on traumatic brain injury, he has developed brain-controlled artificial arms and even now his work revolutionizing prosthetics continues.
Heather Callender-Potters explains the amazing benefits of PharmaJet’s needle-free injection system, which boasts radically diminished cross contamination, better vaccination absorption and higher immune response compared with the needle and syringe system And there’s more!
As a medical student with an entrepreneurial gene, Arjun Desai wanted more; he wanted to DO more. That led him into the medical technology arena and JLABS, a division of Johnson & Johnson Innovation.
With more than 90 US Patents for medical innovations that have played a major role in six venture funded start-ups, not to mention his position as Chief Medical Officer of BiVACOR, the company focused on the implantable artificial heart.
